Closed tender

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins

Details

Published
19 September 2025
Submission
22 October 2025

Tender description

NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/22/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Timeline

  1. Completed: Tender published19 September 2025
    Current notice
  2. Completed: Submission date22 October 2025

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.